LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 6 of 15: End-point mean cell counts and mean normalized growth rate inhibition values for biological replicate 3. - Dataset (ID:20314)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Normalized Growth Rate Inhibition Value
MCF 10A-H2B-mCherry Neratinib
3.1623
 73.90 56.33 169 8150 0.0185 -0.1198
MCF 10A-H2B-mCherry Alpelisib
5.6234
 73.90 56.33 5244 8150 0.6284 0.7783
MCF 10A-H2B-mCherry Neratinib
0.0053333
 73.90 56.33 5286 8150 0.6594 0.7540
MCF 10A-H2B-mCherry Vorinostat
0.1
 73.90 56.33 7794 8150 0.9521 0.9721
MCF 10A-H2B-mCherry Palbociclib
5.6234
 73.90 56.33 989 8150 0.1248 0.4702
MCF 10A-H2B-mCherry Dasatinib
0.01
 73.90 56.33 7429 8150 0.9466 0.9337
MCF 10A-H2B-mCherry Etoposide
0.17783
 73.90 56.33 2779 8150 0.3418 0.5336
MCF 10A-H2B-mCherry Trametinib
0.01
 73.90 56.33 1845 8150 0.2331 0.5978
MCF 10A-H2B-mCherry Vorinostat
0.01
 73.90 56.33 7399 8150 0.9243 0.9034
MCF 10A-H2B-mCherry Dasatinib
3.1623
 73.90 56.33 837 8150 0.1051 0.3643
MCF 10A-H2B-mCherry Trametinib
0.1
 73.90 56.33 1120 8150 0.1439 0.4943
MCF 10A-H2B-mCherry Neratinib
0.018
 73.90 56.33 5995 8150 0.7438 0.8797
MCF 10A-H2B-mCherry Dasatinib
10
 73.90 56.33 270 8150 0.0346 0.0317
MCF 10A-H2B-mCherry Etoposide
0.31623
 73.90 56.33 2903 8150 0.3584 0.6645
MCF 10A-H2B-mCherry Vorinostat
0.17783
 73.90 56.33 5549 8150 0.7006 0.8085
MCF 10A-H2B-mCherry Palbociclib
10
 73.90 56.33 510 8150 0.0630 0.2380
MCF 10A-H2B-mCherry Neratinib
1
 73.90 56.33 609 8150 0.0723 0.2729